12:00 AM
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Biokine, BioLineRx preclinical data

In healthy and chemotherapy induced-thrombocytopenic mice, repeated doses of BL-8040 were superior to Mozobil plerixafor plus G-CSF and non-inferior to thrombopoietin (TPO) in increasing the number of megakaryocytes within the bone marrow. BL-8040 was also superior to Mozobil plus G-CSF in increasing platelet levels in...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >